menu
    • menu

    Company profile for Regenxbio

    NEW Drugs in Dev: 8
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Our gene therapy product candidates are designed to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins that are intended to impact disease. Through a single administration, our product candidates are designed to provide long-lasting e...
    REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Our gene therapy product candidates are designed to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins that are intended to impact disease. Through a single administration, our product candidates are designed to provide long-lasting effects, potentially significantly altering the course of disease and delivering improved patient outcomes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RegenxbioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9600 Blackwell Road, Suite 210, Rockville, MD 20850
    Telephone
    Telephone
    240.552.8181
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.regenxbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof WW Bologna

    Cosmoprof WW Bologna

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof WW Bologna

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Denali’s Hunter Syndrome Drug Gains Focus After REGENXBIO Setback
    Denali’s Hunter Syndrome Drug Gains Focus After REGENXBIO Setback

    16 Mar 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/denalis-hunter-syndrome-candidate-in-the-spotlight-after-regenxbio-rejection

    BIOSPACE
    16 Mar 2026
    Share Share
    Regenxbio Gene Therapy Passes Interim Test As Pivotal Data Loom
    Regenxbio Gene Therapy Passes Interim Test As Pivotal Data Loom

    12 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/regenxbio-posts-clean-safety-profile-dmd-gene-therapy-pivotal-data-loom

    FIERCE BIOTECH
    12 Mar 2026
    Share Share
    Regenxbio Unveils Positive Interim Data from RGX-202 Phase I/II
    Regenxbio Unveils Positive Interim Data from RGX-202 Phase I/II

    11 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regenxbio-reports-new-positive-interim-data-from-phase-iii-affinity-duchenne-trial-of-rgx-202-302711193.html

    PR NEWSWIRE
    11 Mar 2026
    Share Share
    RGNX's Inadequate Risk Disclosures Allegedly Cost $2.40/Share
    RGNX's Inadequate Risk Disclosures Allegedly Cost $2.40/Share

    10 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-10/rgnxs-inadequate-risk-disclosures-allegedly-cost-investors-240share-levi-korsinsky-llp

    PHARMIWEB
    10 Mar 2026
    Share Share
    REGENXBIO Announces Q4, Full-Year 2025 Results & Highlights
    REGENXBIO Announces Q4, Full-Year 2025 Results & Highlights

    05 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regenxbio-reports-fourth-quarter-and-full-year-2025-financial-results-and-operational-highlights-302704786.html

    PR NEWSWIRE
    05 Mar 2026
    Share Share
    REGENXBIO Presents At 2026 (MDA) Clinical & Scientific Conference
    REGENXBIO Presents At 2026 (MDA) Clinical & Scientific Conference

    04 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regenxbio-announces-presentations-at-the-2026-muscular-dystrophy-association-mda-clinical--scientific-conference-302703477.html

    PR NEWSWIRE
    04 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search